Status:
UNKNOWN
Automated Structured Education Based on an App and AI in Chinese Patients With Type 1 Diabetes
Lead Sponsor:
Second Xiangya Hospital of Central South University
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
In recent years, more and more attention has been paid to diabetes self-management. Glycemic control and self-management skills of patients with type 1 diabetes (T1DM) in China are poor. Artificial in...
Detailed Description
This is a single-blinded, 1:1 paralleled group cluster randomized controlled trial (RCT). The intervention will last for 24 weeks. The laboratory staff who test the HbA1c level, the outcome assessor w...
Eligibility Criteria
Inclusion
- Individuals diagnosed with Type 1 Diabetes according to the 1999 World Health Organization report
- Insulin dependence from disease onset
- Aged 18-50 years
- With a disease duration over 6 months
- With a HbA1c level over 7%
- Treated T1DM with multiple daily injections or insulin pump
- Individuals who own smartphone and are capable of using wechat or apps
Exclusion
- Age below 18 years or above 50 years
- Being pregnant
- With mental disorders
- Have any other condition or disease that may hamper from compliance with the protocol or complication of the trial
- Already using a smartphone app for managing diabetes
- Having chronic complications including diabetic retinopathy, diabetic nephropathy or diabetic foot, diabetic neuropathy
Key Trial Info
Start Date :
September 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT04016987
Start Date
September 8 2020
End Date
December 1 2023
Last Update
September 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
Changsha, China, 410011